We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CTKB market cap is 811.11M. The company's latest EPS is USD -0.0929 and P/E is -66.85.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 48.34M | 37.09M | 49.69M | 48M | 58.23M |
Operating Income | -146k | -12.16M | -9.13M | -6.42M | -1.64M |
Net Income | 3.53M | -6.81M | -4.39M | -6.46M | 5.5M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 92.84M | 127.95M | 164.04M | 193.02M |
Operating Income | 13.66M | 9.16M | -1.8M | -27.85M |
Net Income | 3.22M | 0 | 2.58M | -12.15M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 519.48M | 524.58M | 525.05M | 519.43M | 494.46M |
Total Liabilities | 93.93M | 101.12M | 100.88M | 103.91M | 101.39M |
Total Equity | 425.55M | 423.46M | 424.18M | 415.52M | 393.06M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 219.98M | 463.31M | 519.48M | 494.46M |
Total Liabilities | 41.69M | 57.92M | 93.93M | 101.39M |
Total Equity | -16.03M | 405.39M | 425.55M | 393.06M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -12.23M | 2.86M | 8k | -4.23M | 5.28M |
Investing | -55.91M | -168.87M | -166.08M | -122.96M | -93.89M |
Financing | 5.51M | N/A | 216k | -8.06M | -41.81M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 15.16M | 4.63M | -12.23M | 5.28M |
Investing | -1.55M | -20.99M | -55.91M | -93.89M |
Financing | 122.61M | 213.56M | 5.51M | -41.81M |
Market Cap | 811.11M |
Price to Earnings Ratio | -66.85 |
Price to Sales Ratio | 4.21 |
Price to Cash Ratio | 4.86 |
Price to Book Ratio | 2.07 |
Dividend Yield | - |
Shares Outstanding | 130.82M |
Average Volume (1 week) | 603.27k |
Average Volume (1 Month) | 679.28k |
52 Week Change | -45.76% |
52 Week High | 11.705 |
52 Week Low | 3.80 |
Spread (Intraday) | 1.22 (17.18%) |
Company Name | Cytek Biosciences Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.cytekbio.com |
Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions